Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,808 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study.
Uemura H, Kobayashi K, Yokomizo A, Hinotsu S, Horie S, Kakehi Y, Naito S, Nonomura N, Ogawa O, Oya M, Suzuki K, Saito A, Uno S, Akaza H. Uemura H, et al. Among authors: naito s. BJUI Compass. 2021 Aug 20;3(1):26-36. doi: 10.1002/bco2.103. eCollection 2022 Jan. BJUI Compass. 2021. PMID: 35475157 Free PMC article.
The 2nd conference on Asian trends in prostate cancer hormone therapy.
Akaza H, Chang SJ, Chen KK, Esuvaranathan K, Fujioka T, Hirao Y, Hong SJ, Hinotsu S, Kim WJ, Lau W, Lee SE, Murai M, Naito S, Ogawa O, Rim JS, Soebadi DM, Song JM, Tsukamoto T, Umbas R, Usami M, Yang CR, Yoon JH, Zhou L. Akaza H, et al. Among authors: naito s. Gan To Kagaku Ryoho. 2003 Oct;30(10):1533-42. Gan To Kagaku Ryoho. 2003. PMID: 14584292
Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Japanese patients.
Akaza H, Yamaguchi A, Matsuda T, Igawa M, Kumon H, Soeda A, Arai Y, Usami M, Naito S, Kanetake H, Ohashi Y. Akaza H, et al. Among authors: naito s. Jpn J Clin Oncol. 2004 Jan;34(1):20-8. doi: 10.1093/jjco/hyh001. Jpn J Clin Oncol. 2004. PMID: 15020659 Clinical Trial.
The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy.
Akaza H, Naito S, Chang SJ, Chen KK, Cheng C, Choi HY, Fujioka T, Hinotsu S, Hirao Y, Hong SJ, Kim CS, Kim WJ, Lee SE, Murai M, Ogawa O, Rim JS, Soebadi DM, Song JM, Tsukamoto T, Umbas R, Usami M, Xia S, Yang CR, Yoon JH, Zhou L. Akaza H, et al. Among authors: naito s. Gan To Kagaku Ryoho. 2004 Aug;31(8):1285-95. Gan To Kagaku Ryoho. 2004. PMID: 15332559
Randomized controlled trial to evaluate radiotherapy +/- endocrine therapy versus endocrine therapy alone for PSA failure after radical prostatectomy: Japan Clinical Oncology Group Study JCOG 0401.
Yokomizo A, Kawamoto H, Nihei K, Ishizuka N, Kakehi Y, Tobisu K, Naito S; Japan Clinical Oncology Group. Yokomizo A, et al. Among authors: naito s. Jpn J Clin Oncol. 2005 Jan;35(1):34-6. doi: 10.1093/jjco/hyi007. Jpn J Clin Oncol. 2005. PMID: 15681602 Clinical Trial.
1,808 results